Comment on

• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators. Shumaker SA, et al. JAMA. 2003 May 28;289(20):2651-62. doi: 10.1001/jama.289.20.2651. JAMA. 2003. PMID: 12771112 Clinical Trial.
• Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators. Rapp SR, et al. JAMA. 2003 May 28;289(20):2663-72. doi: 10.1001/jama.289.20.2663. JAMA. 2003. PMID: 12771113 Clinical Trial.
• Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

  Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ; WHI Investigators. Wassertheil-Smoller S, et al. JAMA. 2003 May 28;289(20):2673-84. doi: 10.1001/jama.289.20.2673. JAMA. 2003. PMID: 12771114 Clinical Trial.